https://seekingalpha.com/news/4081378-endo-gains-ok-chapter-11-bankruptcy-reorgaanization?source=feed_sector_healthcare
Mar 19, 2024 - Endo International's bankruptcy plan has been approved by a court, allowing for the sale of assets and the reduction of debt. Read more here.
0
sa:1428754362991952557
0
https://www.zacks.com/stock/news/2240060/the-zacks-analyst-blog-highlights-novo-nordisk-tesla-airbnb-oneok-and-cdw?cid=CS-ZC-FT-press_releases-2240060
Mar 13, 2024 - Novo Nordisk, Tesla, Airbnb, ONEOK and CDW are part of the Zacks top Analyst Blog.
zc:9007764428837491961
0
https://www.zacks.com/commentary/2239296/top-research-reports-for-novo-nordisk-tesla-airbnb?cid=CS-ZC-FT-research_daily-2239296
Mar 12, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Tesla, Inc. (TSLA) and Airbnb, Inc. (ABNB).
zc:3817559936962494695
0
https://www.fool.com/earnings/call-transcripts/2024/02/27/oneok-oke-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 27, 2024 - OKE earnings call for the period ending December 31, 2023.
0
fool:-8172289981603614267
0
https://www.zacks.com/stock/news/2232025/here-s-what-key-metrics-tell-us-about-oneok-oke-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2232025
Feb 26, 2024 - While the top- and bottom-line numbers for Oneok (OKE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:5191177285973043007
0
https://www.zacks.com/stock/news/2227986/oneok-inc-oke-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2227986
Feb 19, 2024 - Oneok (OKE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:8870716943290481550
0
https://www.zacks.com/commentary/2225415/q4-earnings-scorecard-and-fresh-analyst-reports-for-nike-airbnb-cvs-health?cid=CS-ZC-FT-research_daily-2225415
Feb 13, 2024 - Today's Research Daily features a real-time earnings season update and new research reports on NIKE (NKE), Airbnb (ABNB), CVS Health (CVS) and others.
zc:-8704463315228845912
0
https://www.zacks.com/stock/news/2225074/oneok-inc-oke-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2225074
Feb 12, 2024 - Oneok Inc. (OKE) closed the most recent trading day at $70.23, moving +1.72% from the previous trading session.
zc:-3394492788828482609
0
https://www.zacks.com/stock/news/2224324/plains-all-american-paa-q4-earnings-top-estimates-sales-lag?cid=CS-ZC-FT-analyst_blog|earnings_article-2224324
Feb 09, 2024 - Plains All American's (PAA) fourth-quarter earnings increase year over year, while revenues decline. Total costs and expenses reduce during the same period.
zc:3802989880602498836
0
https://seekingalpha.com/news/4065121-okyo-pharma-gains-on-receiving-fda-nod-of-ind-for-ok-101-in-neuropathic-corneal-pain?source=feed_sector_healthcare
Feb 09, 2024 - OKYO Pharma rose about 18% in premarket as the company announced that the U.S. Food and Drug Administration (FDA) cleared OK-101 as its first Investigational Ne
0
sa:-15188757792874968
0